The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Biopharmaceutical Buffers Market Research Report 2025
Synopsis
A biopharmaceutical, also known as a biologic(al) medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources.
The global Biopharmaceutical Buffers market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical Buffers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical Buffers.
Report Scope
The Biopharmaceutical Buffers market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biopharmaceutical Buffers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biopharmaceutical Buffers manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GE Healthcare
Thermo Fisher Scientific
Danaher Corporation
Sartorius StedimBiotech
Merck
Eppendorf
Roche
Nova Biomedicals
Lonza
Becton, and Dickinson and Company
GEA
Segment by Type
Sterile Buffer
Non-sterile Buffer
Segment by Application
Recombinant Proteins
Monoclonal Antibodies
Antibiotics
Probiotics
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Biopharmaceutical Buffers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Biopharmaceutical Buffers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
A biopharmaceutical, also known as a biologic(al) medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources.
The global Biopharmaceutical Buffers market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical Buffers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical Buffers.
Report Scope
The Biopharmaceutical Buffers market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biopharmaceutical Buffers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biopharmaceutical Buffers manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GE Healthcare
Thermo Fisher Scientific
Danaher Corporation
Sartorius StedimBiotech
Merck
Eppendorf
Roche
Nova Biomedicals
Lonza
Becton, and Dickinson and Company
GEA
Segment by Type
Sterile Buffer
Non-sterile Buffer
Segment by Application
Recombinant Proteins
Monoclonal Antibodies
Antibiotics
Probiotics
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Biopharmaceutical Buffers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Biopharmaceutical Buffers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Biopharmaceutical Buffers Market Overview
1.1 Product Overview and Scope of Biopharmaceutical Buffers
1.2 Biopharmaceutical Buffers Segment by Type
1.2.1 Global Biopharmaceutical Buffers Market Value Comparison by Type (2024-2030)
1.2.2 Sterile Buffer
1.2.3 Non-sterile Buffer
1.3 Biopharmaceutical Buffers Segment by Application
1.3.1 Global Biopharmaceutical Buffers Market Value by Application: (2024-2030)
1.3.2 Recombinant Proteins
1.3.3 Monoclonal Antibodies
1.3.4 Antibiotics
1.3.5 Probiotics
1.3.6 Other
1.4 Global Biopharmaceutical Buffers Market Size Estimates and Forecasts
1.4.1 Global Biopharmaceutical Buffers Revenue 2019-2030
1.4.2 Global Biopharmaceutical Buffers Sales 2019-2030
1.4.3 Global Biopharmaceutical Buffers Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Biopharmaceutical Buffers Market Competition by Manufacturers
2.1 Global Biopharmaceutical Buffers Sales Market Share by Manufacturers (2019-2024)
2.2 Global Biopharmaceutical Buffers Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Biopharmaceutical Buffers Average Price by Manufacturers (2019-2024)
2.4 Global Biopharmaceutical Buffers Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Biopharmaceutical Buffers, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Biopharmaceutical Buffers, Product Type & Application
2.7 Biopharmaceutical Buffers Market Competitive Situation and Trends
2.7.1 Biopharmaceutical Buffers Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Biopharmaceutical Buffers Players Market Share by Revenue
2.7.3 Global Biopharmaceutical Buffers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Biopharmaceutical Buffers Retrospective Market Scenario by Region
3.1 Global Biopharmaceutical Buffers Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Biopharmaceutical Buffers Global Biopharmaceutical Buffers Sales by Region: 2019-2030
3.2.1 Global Biopharmaceutical Buffers Sales by Region: 2019-2024
3.2.2 Global Biopharmaceutical Buffers Sales by Region: 2025-2030
3.3 Global Biopharmaceutical Buffers Global Biopharmaceutical Buffers Revenue by Region: 2019-2030
3.3.1 Global Biopharmaceutical Buffers Revenue by Region: 2019-2024
3.3.2 Global Biopharmaceutical Buffers Revenue by Region: 2025-2030
3.4 North America Biopharmaceutical Buffers Market Facts & Figures by Country
3.4.1 North America Biopharmaceutical Buffers Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Biopharmaceutical Buffers Sales by Country (2019-2030)
3.4.3 North America Biopharmaceutical Buffers Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Biopharmaceutical Buffers Market Facts & Figures by Country
3.5.1 Europe Biopharmaceutical Buffers Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Biopharmaceutical Buffers Sales by Country (2019-2030)
3.5.3 Europe Biopharmaceutical Buffers Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Biopharmaceutical Buffers Market Facts & Figures by Country
3.6.1 Asia Pacific Biopharmaceutical Buffers Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Biopharmaceutical Buffers Sales by Country (2019-2030)
3.6.3 Asia Pacific Biopharmaceutical Buffers Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Biopharmaceutical Buffers Market Facts & Figures by Country
3.7.1 Latin America Biopharmaceutical Buffers Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Biopharmaceutical Buffers Sales by Country (2019-2030)
3.7.3 Latin America Biopharmaceutical Buffers Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Biopharmaceutical Buffers Market Facts & Figures by Country
3.8.1 Middle East and Africa Biopharmaceutical Buffers Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Biopharmaceutical Buffers Sales by Country (2019-2030)
3.8.3 Middle East and Africa Biopharmaceutical Buffers Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Biopharmaceutical Buffers Sales by Type (2019-2030)
4.1.1 Global Biopharmaceutical Buffers Sales by Type (2019-2024)
4.1.2 Global Biopharmaceutical Buffers Sales by Type (2025-2030)
4.1.3 Global Biopharmaceutical Buffers Sales Market Share by Type (2019-2030)
4.2 Global Biopharmaceutical Buffers Revenue by Type (2019-2030)
4.2.1 Global Biopharmaceutical Buffers Revenue by Type (2019-2024)
4.2.2 Global Biopharmaceutical Buffers Revenue by Type (2025-2030)
4.2.3 Global Biopharmaceutical Buffers Revenue Market Share by Type (2019-2030)
4.3 Global Biopharmaceutical Buffers Price by Type (2019-2030)
5 Segment by Application
5.1 Global Biopharmaceutical Buffers Sales by Application (2019-2030)
5.1.1 Global Biopharmaceutical Buffers Sales by Application (2019-2024)
5.1.2 Global Biopharmaceutical Buffers Sales by Application (2025-2030)
5.1.3 Global Biopharmaceutical Buffers Sales Market Share by Application (2019-2030)
5.2 Global Biopharmaceutical Buffers Revenue by Application (2019-2030)
5.2.1 Global Biopharmaceutical Buffers Revenue by Application (2019-2024)
5.2.2 Global Biopharmaceutical Buffers Revenue by Application (2025-2030)
5.2.3 Global Biopharmaceutical Buffers Revenue Market Share by Application (2019-2030)
5.3 Global Biopharmaceutical Buffers Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GE Healthcare
6.1.1 GE Healthcare Corporation Information
6.1.2 GE Healthcare Description and Business Overview
6.1.3 GE Healthcare Biopharmaceutical Buffers Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GE Healthcare Biopharmaceutical Buffers Product Portfolio
6.1.5 GE Healthcare Recent Developments/Updates
6.2 Thermo Fisher Scientific
6.2.1 Thermo Fisher Scientific Corporation Information
6.2.2 Thermo Fisher Scientific Description and Business Overview
6.2.3 Thermo Fisher Scientific Biopharmaceutical Buffers Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Thermo Fisher Scientific Biopharmaceutical Buffers Product Portfolio
6.2.5 Thermo Fisher Scientific Recent Developments/Updates
6.3 Danaher Corporation
6.3.1 Danaher Corporation Corporation Information
6.3.2 Danaher Corporation Description and Business Overview
6.3.3 Danaher Corporation Biopharmaceutical Buffers Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Danaher Corporation Biopharmaceutical Buffers Product Portfolio
6.3.5 Danaher Corporation Recent Developments/Updates
6.4 Sartorius StedimBiotech
6.4.1 Sartorius StedimBiotech Corporation Information
6.4.2 Sartorius StedimBiotech Description and Business Overview
6.4.3 Sartorius StedimBiotech Biopharmaceutical Buffers Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sartorius StedimBiotech Biopharmaceutical Buffers Product Portfolio
6.4.5 Sartorius StedimBiotech Recent Developments/Updates
6.5 Merck
6.5.1 Merck Corporation Information
6.5.2 Merck Description and Business Overview
6.5.3 Merck Biopharmaceutical Buffers Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Merck Biopharmaceutical Buffers Product Portfolio
6.5.5 Merck Recent Developments/Updates
6.6 Eppendorf
6.6.1 Eppendorf Corporation Information
6.6.2 Eppendorf Description and Business Overview
6.6.3 Eppendorf Biopharmaceutical Buffers Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Eppendorf Biopharmaceutical Buffers Product Portfolio
6.6.5 Eppendorf Recent Developments/Updates
6.7 Roche
6.6.1 Roche Corporation Information
6.6.2 Roche Description and Business Overview
6.6.3 Roche Biopharmaceutical Buffers Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Roche Biopharmaceutical Buffers Product Portfolio
6.7.5 Roche Recent Developments/Updates
6.8 Nova Biomedicals
6.8.1 Nova Biomedicals Corporation Information
6.8.2 Nova Biomedicals Description and Business Overview
6.8.3 Nova Biomedicals Biopharmaceutical Buffers Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Nova Biomedicals Biopharmaceutical Buffers Product Portfolio
6.8.5 Nova Biomedicals Recent Developments/Updates
6.9 Lonza
6.9.1 Lonza Corporation Information
6.9.2 Lonza Description and Business Overview
6.9.3 Lonza Biopharmaceutical Buffers Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Lonza Biopharmaceutical Buffers Product Portfolio
6.9.5 Lonza Recent Developments/Updates
6.10 Becton, and Dickinson and Company
6.10.1 Becton, and Dickinson and Company Corporation Information
6.10.2 Becton, and Dickinson and Company Description and Business Overview
6.10.3 Becton, and Dickinson and Company Biopharmaceutical Buffers Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Becton, and Dickinson and Company Biopharmaceutical Buffers Product Portfolio
6.10.5 Becton, and Dickinson and Company Recent Developments/Updates
6.11 GEA
6.11.1 GEA Corporation Information
6.11.2 GEA Biopharmaceutical Buffers Description and Business Overview
6.11.3 GEA Biopharmaceutical Buffers Sales, Revenue and Gross Margin (2019-2024)
6.11.4 GEA Biopharmaceutical Buffers Product Portfolio
6.11.5 GEA Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Biopharmaceutical Buffers Industry Chain Analysis
7.2 Biopharmaceutical Buffers Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Biopharmaceutical Buffers Production Mode & Process
7.4 Biopharmaceutical Buffers Sales and Marketing
7.4.1 Biopharmaceutical Buffers Sales Channels
7.4.2 Biopharmaceutical Buffers Distributors
7.5 Biopharmaceutical Buffers Customers
8 Biopharmaceutical Buffers Market Dynamics
8.1 Biopharmaceutical Buffers Industry Trends
8.2 Biopharmaceutical Buffers Market Drivers
8.3 Biopharmaceutical Buffers Market Challenges
8.4 Biopharmaceutical Buffers Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
